Editorial: Bioengineered Nanoparticles in Cancer Therapy.

Autor:	Zarrintaj P; Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, United States., Mozafari M; Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran., Vahabi H; Université de Lorraine, CentraleSupélec, LMOPS, Metz, France., Gutiérrez TJ; Grupo de Materiales Compuestos Termoplásticos (CoMP), Instituto de Investigaciones en Ciencia y Tecnología de Materiales (INTEMA), Facultad de Ingeniería, Universidad Nacional de Mar del Plata (UNMdP) y Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Mar del Plata, Argentina., Saeb MR; Department of Resin and Additives, Institute for Color Science and Technology, Tehran, Iran.
Jazyk:	angličtina
Zdroj:	Frontiers in molecular biosciences [Front Mol Biosci] 2021 Jul 13; Vol. 8, pp. 706277. Date of Electronic Publication: 2021 Jul 13 (Print Publication: 2021).
DOI:	10.3389/fmolb.2021.706277
Abstrakt:	Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu